title: Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies.
abstract: BACKGROUND
  Proteinuria is a recognized complication of obesity, but no study has investigated the effect of weight loss in overweight patients with chronic proteinuric nephropathies of different causes.
  
  
  METHODS
  We randomly assigned (in a 2:1 ratio) 30 overweight patients (body mass index [BMI] > 27 kg/m(2)) with diabetic and nondiabetic proteinuric nephropathies to either follow a low-calorie normoproteinic diet or maintain their usual dietary intake for 5 months. The primary outcome was change in urinary protein excretion. Secondary outcomes were changes in renal function (serum creatinine level and Cockcroft-Gault creatinine clearance) and lipid profile.
  
  
  RESULTS
  Patients in the diet group showed a significant decrease in body weight and BMI, whereas patients in the control group showed a significant increase in body weight and BMI (between-group comparison, P < 0.05). Mean weight loss in the diet group was 4.1% +/- 3%, and 14 of 20 patients in this group lost more than 3%. Proteinuria decreased by 31.2% +/- 37% in the diet group (from protein of 2.8 +/- 1.4 to 1.9 +/- 1.4 g/24 h; P < 0.005), whereas it tended to increase in the control group (between-group comparison, P < 0.05). Changes in renal function did not differ significantly between groups, although renal function remained stable in the diet group and showed significant worsening in the control group. Serum triglyceride levels remained stable in the diet group and tended to increase in the control group (between-group comparison, P < 0.05).
  
  
  CONCLUSIONS
  Moderate weight loss in overweight patients with chronic proteinuric nephropathies induces a significant decrease in proteinuria. Am J Kidney Dis 41:319-327.
authors.affiliation: Departments of Nephrology and Endocrinology, Hospital Universitario 12 de Octubre, Madrid, Spain.
authors.forename: Enrique
authors.initials: E
authors.lastname: Morales
authors.forename: Ma Angeles
authors.initials: MA
authors.lastname: Valero
authors.forename: Miguel
authors.initials: M
authors.lastname: León
authors.forename: Eduardo
authors.initials: E
authors.lastname: Hernández
authors.forename: Manuel
authors.initials: M
authors.lastname: Praga
mesh_terms: D000293:Adolescent; D000328:Adult; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000178:diet therapy / Q000503:physiopathology / Q000652:urine; D003928:Diabetic Nephropathies / Q000178:diet therapy / Q000209:etiology / Q000503:physiopathology / Q000652:urine; D004038:Diet, Reducing / Q000379:methods; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology / Q000652:urine; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications* / Q000178:diet therapy / Q000503:physiopathology* / Q000652:urine; D011507:Proteinuria / Q000178:diet therapy / Q000209:etiology* / Q000503:physiopathology* / Q000652:urine; D016896:Treatment Outcome; D015431:Weight Loss / Q000502:physiology*